Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.43B | $1.40B | $5.60B | $1.50B | $1.66B |
| Total Operating Revenue | $1.43B | $1.40B | $5.60B | $1.50B | $1.66B |
| Cost of Revenue | $688.66M | $692.41M | $2.57B | $604.96M | $659.84M |
| Gross Profit | $739.95M | $704.03M | $3.04B | $899.97M | $997.79M |
| Operating Expense | $491.32M | $476.06M | $2.14B | $643.69M | $648.38M |
| Selling and Admin Expenses | $487.64M | $468.77M | $2.09B | $622.77M | $650.25M |
| -General & Admin Expense | $487.64M | $468.77M | $2.09B | $622.77M | $650.25M |
| Other Operating Expenses | $3.68M | $7.28M | $52.71M | $20.92M | -$1.87M |
| Operating Profit | $248.63M | $227.97M | $892.72M | $256.28M | $349.41M |
| Net Non-Operating Interest Income (Expense) | -$90.71M | -$80.92M | -$144.74M | -$55.23M | -$58.55M |
| Non-Operating Interest Income | $65.65M | $108.64M | $622.72M | $130.87M | $144.47M |
| Non-Operating Interest Expense | $156.35M | $189.56M | $767.46M | $186.10M | $203.02M |
| Other Income (Expense) | $228.01M | $165.87M | $538.91M | $5.60M | $361.41M |
| Gain on Sale of Security | $249.11M | $141.31M | $858.66M | $260.85M | $368.68M |
| Other Non-Operating Income (Expenses) | -$21.09M | $1.46M | -$319.75M | -$255.25M | -$7.26M |
| Pretax Profit | $385.94M | $312.92M | $1.29B | $206.65M | $652.27M |
| Tax | $72.98M | $59.87M | $198.54M | $8.15M | $111.89M |
| Net Profit | $312.97M | $253.05M | $1.09B | $198.50M | $540.38M |
| Profit from Continuing Operations | $312.97M | $253.05M | $1.09B | $198.50M | $540.38M |
| Minority Interests | $162.33M | $110.46M | $561.00M | $144.25M | $251.50M |
| Net Income to Parent Company | $150.64M | $142.59M | $527.36M | $54.25M | $288.88M |
| Preferred Stock Dividends | $25.31M | $25.31M | $101.25M | $25.31M | $25.31M |
| Net Income to Common Stockholders | $125.32M | $117.28M | -$602.00M | -$230.37M | $5.70M |
| Basic EPS | $0.49 | $0.46 | $1.71 | $0.08 | $1.15 |
| Diluted EPS | $0.49 | $0.46 | $1.71 | $0.08 | $1.15 |
| Dividend Per Share | $1.35 | $1.35 | $4.48 | $1.12 | $1.12 |
| Special Income (Charges) | – | $23.10M | – | – | – |
| -Less:Restructuring and Mergern & Acquisition | – | -$23.10M | – | – | – |
| Other Preferred Stock Dividends | – | – | $1.03B | $259.30M | $257.87M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $29.63B | $28.39B | $28.63B | $28.63B | $27.03B |
| Total Current Assets | $7.65B | $7.53B | $8.87B | $8.87B | $8.97B |
| Cash and Cash Equivalents & Short-Term Investments | $1.85B | $1.44B | $1.45B | $1.45B | $1.50B |
| -Cash and Cash Equivalents | $1.85B | $1.44B | $1.45B | $1.45B | $1.50B |
| Receivables | $5.79B | $6.08B | $7.41B | $7.41B | $7.43B |
| -Loans Receivable | $4.30B | $4.64B | $5.51B | $5.51B | $5.95B |
| -Due from Related Parties Current | $1.38B | $1.35B | $1.42B | $1.42B | $1.33B |
| -Other Receivables | $113.29M | $95.08M | $260.67M | $260.67M | $147.80M |
| Restricted Cash | $5.40M | $11.11M | $13.22M | $13.22M | $31.92M |
| Total Non-Current Assets | $21.98B | $20.87B | $19.76B | $19.76B | $18.07B |
| Net PPE | $633.39M | $564.57M | $745.18M | $745.18M | $526.04M |
| -Gross PPE | $633.39M | $564.57M | $861.42M | $861.42M | $526.04M |
| Investments and Advances | $14.63B | $13.58B | $12.83B | $12.83B | $11.03B |
| -Available for Sale Securities | $4.87B | $3.90B | $3.51B | $3.51B | $2.51B |
| -Held to Maturity Securities | $251.82M | $261.67M | $292.16M | $292.16M | $322.23M |
| -Long Term Equity Investment | $9.51B | $9.42B | $9.03B | $9.03B | $8.20B |
| Goodwill and Other Intangible Assets | $5.56B | $5.61B | $5.57B | $5.57B | $5.60B |
| -Goodwill | $3.46B | $3.46B | $3.45B | $3.45B | $3.44B |
| -Other Intangible Assets | $2.10B | $2.14B | $2.12B | $2.12B | $2.17B |
| Other Non-Current Assets | $1.16B | $1.12B | $263.88M | $263.88M | $910.40M |
| Total Liabilities | $21.03B | $20.04B | $19.96B | $19.96B | $18.43B |
| Total Current Liabilities | $8.03B | $7.67B | $7.49B | $7.49B | $5.80B |
| Payables | $5.50B | $5.44B | $5.24B | $5.24B | $5.02B |
| -Accounts Payable | $1.35B | $1.34B | $1.31B | $1.31B | $1.04B |
| -Due to Related Parties Current | $764.77M | $796.80M | $810.41M | $810.41M | $626.59M |
| -Other Payable | $3.38B | $3.30B | $3.12B | $3.12B | $3.35B |
| Short-Term Debt and Capital Lease Obligation | $2.53B | $2.23B | $2.25B | $2.25B | $785.28M |
| -Current Debt | $2.53B | $2.23B | $2.25B | $2.25B | $785.28M |
| Total Non-Current Liabilities | $13.00B | $12.36B | $12.47B | $12.47B | $12.62B |
| Long Term Debt and Capital Lease Obligation | $12.34B | $11.92B | $11.97B | $11.97B | $11.94B |
| -Long Term Debt | $11.53B | $11.19B | $11.30B | $11.30B | $11.26B |
| -Long Term Capital Lease Obligation | $812.60M | $730.13M | $670.00M | $670.00M | $676.37M |
| Employee Benefits | $635.16M | $422.52M | $472.98M | $472.98M | $656.74M |
| Convertible preferred securities | $25.65M | $23.88M | $25.30M | $25.30M | $25.75M |
| Total Equity | $8.60B | $8.36B | $8.68B | $8.68B | $8.61B |
| Stockholders' Equity | $3.97B | $4.03B | $4.28B | $4.28B | $4.47B |
| Capital Stock | $1.46B | $1.46B | $1.46B | $1.46B | $1.46B |
| -Common Stock | $3.30M | $3.30M | $3.27M | $3.27M | $3.27M |
| -Preferred Stock | $1.46B | $1.46B | $1.46B | $1.46B | $1.46B |
| Additional Paid-In Capital | $4.35B | $4.20B | $4.24B | $4.24B | $4.20B |
| Retained Earnings | -$1.85B | -$1.66B | -$1.45B | -$1.45B | -$1.22B |
| Gains/Losses Not Affecting Retained Earnings | $13.12M | $13.99M | $21.74M | $21.74M | $29.76M |
| Minority Interests | $4.63B | $4.33B | $4.40B | $4.40B | $4.13B |
| -Accounts Receivable | – | – | $188.14M | $188.14M | – |
| -Taxes Receivable | – | – | $31.74M | $31.74M | – |
| -Accumulated Depreciation | – | – | -$116.24M | -$116.24M | – |
| Non-Current Deferred Assets | – | – | $352.29M | $352.29M | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$351.45M | $406.52M | $3.27B | -$483.69M | $1.34B |
| Net cash flow from continuing operations | -$351.45M | $406.52M | $3.27B | -$483.69M | $1.34B |
| Net Income from Continuing Operations | $312.97M | $253.05M | $1.09B | $198.50M | $540.38M |
| Other Non-Cash Items | -$307.44M | -$99.04M | $1.79B | -$324.16M | $486.55M |
| Change in Working Capital | -$356.97M | $252.51M | $273.24M | -$475.28M | $313.82M |
| Net cash flow from investing | -$33.20M | -$7.17M | -$1.80B | -$21.08M | -$14.95M |
| Net Cash Flow from Continuing Investing Activities | -$33.20M | -$7.17M | -$1.80B | -$21.08M | -$14.95M |
| Net PPE Purchase and Sale | -$33.05M | -$15.64M | -$72.18M | -$15.79M | -$11.49M |
| Net Business Purchase and Sale | -$147,000.00 | $8.48M | -$1.73B | -$5.29M | -$3.46M |
| Financing Cash Flow | $370.86M | -$292.91M | -$2.43B | $542.86M | -$1.23B |
| Net Cash Flow from Continuing Financing Activities | $370.86M | -$292.91M | -$2.43B | $542.86M | -$1.23B |
| Net Issuance Payments Of Debt | $634.14M | $277.70M | $293.08M | $954.56M | -$371.38M |
| Cash Dividends Paid | -$513.76M | -$522.75M | -$1.76B | -$459.75M | -$423.68M |
| Net Other Financing Charges | $250.48M | -$47.86M | -$963.56M | $48.05M | -$430.04M |
| Ending Cash Balance | $557.09M | $568.78M | $488.90M | $488.90M | $496.67M |
| Net Change in Cash | -$13.79M | $106.44M | -$963.85M | $38.09M | $100.69M |
| Beginning Cash Balance | $568.78M | $488.90M | $1.51B | $496.67M | $509.66M |
| Effect of Exchange Rate Changes | $2.10M | -$26.56M | -$55.23M | -$45.86M | -$113.68M |
| Free Cash Flow | -$384.50M | $390.87M | $3.19B | -$499.48M | $1.33B |
| Gain/Loss from Continuing Operations | – | – | -$866.45M | – | – |
| Depreciation & Depletion & Amortization | – | – | $243.15M | – | – |
| -Change in Receivables | – | – | -$37.80M | – | – |
| -Change in Payables and Accrued Expense | – | – | $91.96M | – | – |
| -Change in Other Current Assets | – | – | -$69.15M | – | – |
| -Change in Other Current Liabilities | – | – | -$28.92M | – | – |
| -Change In Other Working Capital | – | – | $317.15M | – | – |
| Net Common Stock Issuance | – | – | $0.00 | $0.00 | – |
| Net Preferred Stock Issuance | – | – | $0.00 | – | – |
| Proceeds from Stock Option Exercised | – | – | $0.00 | $0.00 | – |
No comments yet — be the first to weigh in on ARES.